Order Article Reprints

Hasso-Agopsowicz M, Spasenoska D, Jansen MPM, Masresha BG, Pastor D, Gebrekidan AH, Silalahi O, Woolford J, Kisakye A, Kahn A-L, et al. Exploring Important Attributes, the Potential Use Cases and Feasibility of Introduction of Measles and Rubella Microarray Patches (MR-MAPs): Insights from Nine Countries. Vaccines. 2024; 12(9):1084. https://doi.org/10.3390/vaccines12091084

Hasso-Agopsowicz, Mateusz, Dijana Spasenoska, Maarten Paul Maria Jansen, Balcha Girma Masresha, Desiree Pastor, Abay Hagos Gebrekidan, Olivi Silalahi, Janice Woolford, Annet Kisakye, Anna-Lea Kahn, and et al. 2024. "Exploring Important Attributes, the Potential Use Cases and Feasibility of Introduction of Measles and Rubella Microarray Patches (MR-MAPs): Insights from Nine Countries" Vaccines 12, no. 9: 1084. https://doi.org/10.3390/vaccines12091084

Hasso-Agopsowicz, M., Spasenoska, D., Jansen, M. P. M., Masresha, B. G., Pastor, D., Gebrekidan, A. H., Silalahi, O., Woolford, J., Kisakye, A., Kahn, A.-L., & Giersing, B. (2024). Exploring Important Attributes, the Potential Use Cases and Feasibility of Introduction of Measles and Rubella Microarray Patches (MR-MAPs): Insights from Nine Countries. Vaccines, 12(9), 1084. https://doi.org/10.3390/vaccines12091084